Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Regen Ther
2021 Aug 24;18:275-280. doi: 10.1016/j.reth.2021.08.001.
Show Gene links
Show Anatomy links
Modeling human congenital disorders with neural crest developmental defects using patient-derived induced pluripotent stem cells.
Okuno H
,
Okano H
.
???displayArticle.abstract???
The neural crest is said to be the fourth germ layer in addition to the ectoderm, mesoderm and endoderm because of its ability to differentiate into a variety of cells that contribute to the various tissues of the vertebrate body. Neural crest cells (NCCs) can be divided into three functional groups: cranial NCCs, cardiac NCCs and trunk NCCs. Defects related to NCCs can contribute to a broad spectrum of syndromes known as neurocristopathies. Studies on the neural crest have been carried out using animal models such as Xenopus, chicks, and mice. However, the precise control of human NCC development has not been elucidated in detail due to species differences. Using induced pluripotent stem cell (iPSC) technology, we developed an in vitro disease model of neurocristopathy by inducing the differentiation of patient-derived iPSCs into NCCs and/or neural crest derivatives. It is now possible to address complicated questions regarding the pathogenetic mechanisms of neurocristopathies by characterizing cellular biological features and transcriptomes and by transplanting patient-derived NCCs in vivo. Here, we provide some examples that elucidate the pathophysiology of neurocristopathies using disease modeling via iPSCs.
Fig. 1. Overview of NCCs differentiation along the anteriorâposterior axis of the embryo. Only cranial NCCs can differentiated into bone and cartilage in addition to melanocyte, cranial neurons and glial cells and odontoblasts. Cardiac NCCs migrate into 3rd-6th pharyngeal arches and give rise to aorticopulmonary septum, smooth muscle of the aorta and pulmonary artery and valvular tissue and cardiac neurons. Vagal and Sacral NCCs consists of enteric nervous system. Trunk NCCs migrate dorsolateral and ventrolateral. The former group give rise to melanocyte and the latter give rise to chromaffin cells, known as endocrine cells in adrenal glands, and the neurons of the sympathetic nervous system.
Fig. 2. Schematic overview of genes in the 22q11.2 critical region. Schematic overview of 3 Mb in the 22q11.2 region. The gray columns A, B, C, D indicate blocks of low-copy repeats, named LCR22s. Breakpoints of the deletion mostly occur in these LCR22s. Eighty-five percent of patients with chr.22q11.2 deletion syndrome have a 3 Mb deletion, and 5% harbor a 1.5 Mb deletion. Forty-four coding genes and 9 noncoding genes are located in this region. The genes listed in blue were reported to be associated with schizophrenia. TBX1 (shown in red) is known as a cardinal gene of chr.22q11.2 deletion syndrome. Eight coding genes were reported to cause autosomal recessive syndromes. ND: neural development, NC: neural crest, PA: pharyngeal arches.
Fig. 3. Defective migration of CHARGE iPSC-NCCs. A. Features of the enrolled CHARGE patients. Both patients had typical CHARGE syndrome phenotypes. B. Representative image of control (green) and CHARGE (red) iPSC-NCCs in chick embryos at 36 h after transplantation into the dorsal side of the developing neural tube at the hindbrain level in a chick embryo at HH-stage 10. C. Venn diagram of 338 differentially expressed genes between control- and CHARGE-iPSC-NCCs and 12,159 listed genes as targets of CHD7 in the ChIP-seq datasets from the ENCODE transcription factor target database.
Acloque,
Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease.
2009, Pubmed
Acloque,
Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease.
2009,
Pubmed
Asada,
Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice.
2011,
Pubmed
Baggiolini,
Premigratory and migratory neural crest cells are multipotent in vivo.
2015,
Pubmed
Bajpai,
CHD7 cooperates with PBAF to control multipotent neural crest formation.
2010,
Pubmed
,
Xenbase
Baker,
Ephs and ephrins during early stages of chick embryogenesis.
2003,
Pubmed
Bassett,
22q11 deletion syndrome: a genetic subtype of schizophrenia.
1999,
Pubmed
Benish,
Letter: "The neurocristopathies: a unifying concept of disease arising in neural crest development".
1975,
Pubmed
Blake,
CHARGE syndrome.
2006,
Pubmed
Borchers,
Xenopus cadherin-11 restrains cranial neural crest migration and influences neural crest specification.
2001,
Pubmed
,
Xenbase
Bundo,
Increased l1 retrotransposition in the neuronal genome in schizophrenia.
2014,
Pubmed
Carrió,
Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas.
2019,
Pubmed
Dupin,
The issue of the multipotency of the neural crest cells.
2018,
Pubmed
Fattahi,
Deriving human ENS lineages for cell therapy and drug discovery in Hirschsprung disease.
2016,
Pubmed
Garg,
Tbx1, a DiGeorge syndrome candidate gene, is regulated by sonic hedgehog during pharyngeal arch development.
2001,
Pubmed
Huang,
Induction of the neural crest and the opportunities of life on the edge.
2004,
Pubmed
,
Xenbase
Hutson,
Model systems for the study of heart development and disease. Cardiac neural crest and conotruncal malformations.
2007,
Pubmed
Jerome,
DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1.
2001,
Pubmed
Khan,
Neuronal defects in a human cellular model of 22q11.2 deletion syndrome.
2020,
Pubmed
Kirby,
Neural crest cells contribute to normal aorticopulmonary septation.
1983,
Pubmed
Kraft,
Embryonic retinoid concentrations after maternal intake of isotretinoin.
1989,
Pubmed
Kulesa,
Cranial neural crest migration: new rules for an old road.
2010,
Pubmed
Le Douarin,
The Pluripotency of Neural Crest Cells and Their Role in Brain Development.
2016,
Pubmed
Le Douarin,
The "beginnings" of the neural crest.
2018,
Pubmed
Le Douarin,
The migration of neural crest cells to the wall of the digestive tract in avian embryo.
1973,
Pubmed
Le Douarin,
The neural crest in vertebrate evolution.
2012,
Pubmed
Li,
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells.
2018,
Pubmed
Martin,
Chromatin remodeling in development and disease: focus on CHD7.
2010,
Pubmed
McDonald-McGinn,
22q11.2 deletion syndrome.
2015,
Pubmed
Minoux,
Molecular mechanisms of cranial neural crest cell migration and patterning in craniofacial development.
2010,
Pubmed
Morrow,
Molecular genetics of 22q11.2 deletion syndrome.
2018,
Pubmed
Nagashimada,
Autonomic neurocristopathy-associated mutations in PHOX2B dysregulate Sox10 expression.
2012,
Pubmed
Niethamer,
EPHRIN-B1 Mosaicism Drives Cell Segregation in Craniofrontonasal Syndrome hiPSC-Derived Neuroepithelial Cells.
2017,
Pubmed
Obermayr,
Development and developmental disorders of the enteric nervous system.
2013,
Pubmed
Okuno,
CHARGE syndrome modeling using patient-iPSCs reveals defective migration of neural crest cells harboring CHD7 mutations.
2017,
Pubmed
Rao,
Enteric nervous system development: what could possibly go wrong?
2018,
Pubmed
Rouillard,
The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins.
2016,
Pubmed
Später,
A HCN4+ cardiomyogenic progenitor derived from the first heart field and human pluripotent stem cells.
2013,
Pubmed
Takahashi,
Tissue interactions in neural crest cell development and disease.
2013,
Pubmed
Takahashi,
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.
2006,
Pubmed
Toyoshima,
Analysis of induced pluripotent stem cells carrying 22q11.2 deletion.
2016,
Pubmed
Yuan,
Premigratory neural crest stem cells generate enteric neurons populating the mouse colon and regulating peristalsis in tissue-engineered intestine.
2021,
Pubmed